Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Sanomedics, Inc. | simh_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 21, 2014
|
Sanomedics International Holdings, Inc.
|
|
(Exact name of registrant as specified in its charter)
|
|
Delaware
|
000-54167
|
27-3320809
|
||
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
444 Brickell Avenue, Suite 415, Miami, Florida
|
33131
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code (305)433-7814
|
not applicable
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On February 25, 2014 Sanomedics International Holdings, Inc. ("we”, "us” or “our”) issued a press release announcing that on February 21, 2014, it had entered into a non-binding Letter of Intent to acquire all of the issued and outstanding equity of a national provider of professional health care services and solutions to public and private institutions and multinational corporations throughout the world. The press release is attached hereto as Exhibit 99.1 and incorporated herein by this reference.
Pursuant to General Instruction B.2 of Form 8-K, the information in this Item 7.01 of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject to the liabilities of that section, nor is it incorporated by reference into any filing of Sanomedics International Holdings, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| 99.1 | Press release of Sanomedics International Holdings, Inc., dated February 25, 2014 (furnished herewith) |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Sanomedics International Holdings, Inc. | |||
|
Date: February 25, 2014
|
By:
|
/s/ David C. Langle | |
| David C. Langle, Chief Financial Officer | |||
3